Augmedix (OTCMKTS:AUGX – Get Rating) and Relx (NYSE:RELX – Get Rating) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations. Volatility and Risk Augmedix has a beta of -0.76, meaning that its […]
Cowen Prime Advisors LLC acquired a new position in Augmedix, Inc. (OTCMKTS:AUGX – Get Rating) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 742,100 shares of the company’s stock, valued at approximately $1,158,000. Cowen Prime Advisors LLC owned 1.98% of Augmedix as of its […]
Perkins Capital Management Inc. increased its stake in shares of Augmedix, Inc. (OTCMKTS:AUGX – Get Rating) by 276.0% during the 4th quarter, Holdings Channel.com reports. The fund owned 1,680,428 shares of the company’s stock after purchasing an additional 1,233,528 shares during the quarter. Augmedix comprises about 2.8% of Perkins Capital Management Inc.’s portfolio, making the […]
Benchmark reiterated their buy rating on shares of Augmedix (OTCMKTS:AUGX – Get Rating) in a research note published on Friday, Benzinga reports. Benchmark currently has a $5.00 price objective on the stock. AUGX has been the topic of several other reports. Maxim Group boosted their price target on shares of Augmedix from $4.00 to $5.00 […]
Augmedix (OTCMKTS:AUGX – Get Rating) is one of 228 public companies in the “Business services, not elsewhere classified” industry, but how does it weigh in compared to its competitors? We will compare Augmedix to similar companies based on the strength of its valuation, risk, analyst recommendations, profitability, dividends, earnings and institutional ownership. Earnings & Valuation […]